RE:PAIR GENOMICS
LIVE

Serial Number

99729812

Owner

Re:Pair Genomics Inc.

Attorney

Lindsay M.R. Jones

Filing Date

Mar 27, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RE:PAIR GENOMICS Trademark

Serial Number: 99729812

RE:PAIR GENOMICS is a trademark filed by Re:Pair Genomics Inc. on March 27, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Re:Pair Genomics Inc.

33 National Pine Drive
Vaughan, ON L6A 3M2 , CA

Entity Type: 03

Trademark Details

Filing Date

March 27, 2026

Registration Date

Not Registered

Goods & Services

Design and development of synthetic DNA regulatory elements using artificial intelligence and machine learning algorithms for scientific and medical research; Bioinformatics and computational biology services for analyzing, evaluating, optimizing, and predicting the performance of genetic constructs and sequences; Software as a service (SaaS) and Platform-as-a-service featuring software for designing, generating, modeling, and validating customized DNA sequences and regulatory elements; Providing temporary use of non downloadable software for computational genomics, genetic sequence evaluation, cell type specificity prediction, and off target expression analysis; Scientific and technological research services in the fields of genomics, synthetic biology, gene regulation, and computational design of regulatory elements; Scientific analysis and research services in the fields of genomics, genetics, epigenomics, transcriptomics, and synthetic biology

Downloadable computer software for designing, generating, analyzing, and modeling synthetic DNA regulatory elements using machine learning algorithms; downloadable bioinformatics software for genomic, epigenomic, transcriptomic, and multi omics data analysis for scientific and medical research; Downloadable software for evaluating genetic sequence features and predicting regulatory element performance; Downloadable computer software for compiling, organizing, and visualizing genomic, epigenomic, and synthetic biology research data; Downloadable scientific software for use in gene therapy and cell therapy research namely for regulatory element selection and construct design

Genomic analysis services; Gene therapy research services for medical and scientific purposes; Providing medical and scientific research information in the fields of genetics, genomics, gene therapy, cell therapy, and synthetic biology, namely information relating to the design, selection, and application of synthetic DNA regulatory elements; Scientific consultation and advisory services relating to genomic analysis, genetic sequence design, gene expressiontargeting, and computational design of synthetic regulatory elements for research and therapeutic development; Providing online information relating to genomic analysis, synthetic regulatory element development, and gene therapy research applications

Filing History

APPLICATION FILING RECEIPT MAILED
Mar 27, 2026 MAFR
NEW APPLICATION ENTERED
Mar 27, 2026 NWAP